Niki BioSolutions, Inc.(NIKI)

Biotechnology · Princeton, NJ

$4.69-0.04 (-0.81%)

Delayed quote: Oct 6, 2026, 2:38 PM EDT

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T19:02:44.813Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:02:44.813Z.

Quote observation: 2026-10-06T18:38:03.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 381,940
Total debt · period ending 2025-12-31: 3,442,928
Cash · period ending 2025-12-31: 3,452,891
TTM free cash flow · period ending 2025-12-31: N/A

FMP input reference: 05f4ae4a030aaca39f2691a5695262832c6d48704f11c5316ed8238ac0b3761e

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

NIKI EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

NIKI Competitors' EV/FCF Ratio

NIKI

Niki BioSolutions, Inc.

Current

Market Cap

$381940.00

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VRAX

Virax Biolabs Group Limited

vs NIKI

Market Cap

$352721.00

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

XRTX

XORTX Therapeutics Inc.

vs NIKI

Market Cap

$484571.00

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SPRC

SciSparc Ltd.

vs NIKI

Market Cap

$245237.00

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VIVS

VivoSim Labs, Inc.

vs NIKI

Market Cap

$530421.00

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HCWB

HCW Biologics Inc.

vs NIKI

Market Cap

$563178.00

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SLXN

Silexion Therapeutics Ltd.

vs NIKI

Market Cap

$109777.00

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PBM

Psyence Biomedical Ltd.

vs NIKI

Market Cap

$96088.00

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CDT

CDT Equity Inc.

vs NIKI

Market Cap

$674464.00

EV/FCF Ratio

N/A

TTM Avg

2.87x

3Y Avg

2.87x

5Y Avg

2.87x

PRFX

PRF Technologies Ltd.

vs NIKI

Market Cap

$72479.00

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Niki BioSolutions, Inc. (NIKI)	$381940.00	N/A	N/A	N/A	N/A
Virax Biolabs Group Limited (VRAX)vs ›	$352721.00	N/A	N/A	N/A	N/A
XORTX Therapeutics Inc. (XRTX)vs ›	$484571.00	N/A	N/A	N/A	N/A
SciSparc Ltd. (SPRC)vs ›	$245237.00	N/A	N/A	N/A	N/A
VivoSim Labs, Inc. (VIVS)vs ›	$530421.00	N/A	N/A	N/A	N/A
HCW Biologics Inc. (HCWB)vs ›	$563178.00	N/A	N/A	N/A	N/A
Silexion Therapeutics Ltd. (SLXN)vs ›	$109777.00	N/A	N/A	N/A	N/A
Psyence Biomedical Ltd. (PBM)vs ›	$96088.00	N/A	N/A	N/A	N/A
CDT Equity Inc. (CDT)vs ›	$674464.00	N/A	2.87x	2.87x	2.87x
PRF Technologies Ltd. (PRFX)vs ›	$72479.00	N/A	N/A	N/A	N/A

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio: N/A

NIKI EV/FCF Ratio Metrics

NIKI Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics